BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1609 related articles for article (PubMed ID: 31332738)

  • 1. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis, cannabidiol, and epilepsy--from receptors to clinical response.
    Szaflarski JP; Bebin EM
    Epilepsy Behav; 2014 Dec; 41():277-82. PubMed ID: 25282526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ
    Boggs DL; Nguyen JD; Morgenson D; Taffe MA; Ranganathan M
    Neuropsychopharmacology; 2018 Jan; 43(1):142-154. PubMed ID: 28875990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
    Dos Santos RG; Hallak JEC; Crippa JAS
    Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Cannabidiol Safety: A Review.
    Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
    Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
    Pertwee RG
    Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cannabimimetic effects of selected minor cannabinoids and Terpenoids in mice.
    Wiley JL; Marusich JA; Blough BE; Namjoshi O; Brackeen M; Akinfiresoye LR; Walker TD; Prioleau C; Barrus DG; Gamage TF
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jun; 132():110984. PubMed ID: 38417478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting cannabis products to pharmaceutical drugs.
    Koltai H; Poulin P; Namdar D
    Eur J Pharm Sci; 2019 Apr; 132():118-120. PubMed ID: 30851400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol in medical marijuana: Research vistas and potential opportunities.
    Rong C; Lee Y; Carmona NE; Cha DS; Ragguett RM; Rosenblat JD; Mansur RB; Ho RC; McIntyre RS
    Pharmacol Res; 2017 Jul; 121():213-218. PubMed ID: 28501518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol.
    Linciano P; Citti C; Russo F; Tolomeo F; Laganà A; Capriotti AL; Luongo L; Iannotta M; Belardo C; Maione S; Forni F; Vandelli MA; Gigli G; Cannazza G
    Sci Rep; 2020 Dec; 10(1):22019. PubMed ID: 33328530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical considerations in medical cannabis administration and dosing.
    MacCallum CA; Russo EB
    Eur J Intern Med; 2018 Mar; 49():12-19. PubMed ID: 29307505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping cannabis potency in medical and recreational programs in the United States.
    Cash MC; Cunnane K; Fan C; Romero-Sandoval EA
    PLoS One; 2020; 15(3):e0230167. PubMed ID: 32214334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Δ
    Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
    J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
    Todd SM; Arnold JC
    Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approved cannabinoids for medical purposes - Comparative systematic review and meta-analysis for sleep and appetite.
    Spanagel R; Bilbao A
    Neuropharmacology; 2021 Sep; 196():108680. PubMed ID: 34181977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis and the exocannabinoid and endocannabinoid systems. Their use and controversies.
    Millán-Guerrero RO; Isais-Millán S
    Gac Med Mex; 2019; 155(5):471-474. PubMed ID: 32091020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Critical Review of the Role of the Cannabinoid Compounds Δ
    Jones É; Vlachou S
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33113776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo pharmacological activity of minor cannabinoids isolated from Cannabis sativa.
    Zagzoog A; Mohamed KA; Kim HJJ; Kim ED; Frank CS; Black T; Jadhav PD; Holbrook LA; Laprairie RB
    Sci Rep; 2020 Nov; 10(1):20405. PubMed ID: 33230154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 81.